Published in Dig Liver Dis on September 25, 2008
Medical therapies for hepatocellular carcinoma: a critical view of the evidence. Nat Rev Gastroenterol Hepatol (2012) 1.57
Cytokine induced killer cells as promising immunotherapy for solid tumors. J Cancer (2011) 1.45
Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety. Exp Hematol Oncol (2012) 1.18
Cytokine-induced killer cells promote antitumor immunity. J Transl Med (2013) 1.16
Immunological landscape and immunotherapy of hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2015) 1.06
Cytokine-induced killer (CIK) cells in cancer immunotherapy: report of the international registry on CIK cells (IRCC). J Cancer Res Clin Oncol (2014) 0.99
Adoptive immunotherapy in postoperative hepatocellular carcinoma: a systemic review. PLoS One (2012) 0.95
The effects of cytokine-induced killer cells for the treatment of patients with solid tumors: a clinical retrospective study. J Cancer Res Clin Oncol (2012) 0.95
Optimal adjuvant therapy for resected hepatocellular carcinoma: a systematic review with network meta-analysis. Oncotarget (2015) 0.90
A randomized phase II study of autologous cytokine-induced killer cells in treatment of hepatocellular carcinoma. J Clin Immunol (2013) 0.89
Immunotherapy for hepatocellular carcinoma: From basic research to clinical use. World J Hepatol (2015) 0.88
Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors. J Immunol Res (2014) 0.86
Immune-based Therapy Clinical Trials in Hepatocellular Carcinoma. J Clin Cell Immunol (2015) 0.84
A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma. Can J Gastroenterol (2013) 0.83
Clinical application of adoptive T cell therapy in solid tumors. Med Sci Monit (2014) 0.82
Coculturing dendritic cells with zoledronate acid efficiently enhance the anti-tumor effects of cytokine-induced killer cells. J Clin Immunol (2010) 0.82
Human leukocyte antigen-haploidentical donor-derived cytokine-induced killer cells are safe and prolong the survival of patients with advanced non-small cell lung cancer. Oncol Lett (2014) 0.81
A nomogram for predicting the benefit of adjuvant cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma. Sci Rep (2015) 0.81
A randomized controlled trial on patients with or without adjuvant autologous cytokine-induced killer cells after curative resection for hepatocellular carcinoma. Oncoimmunology (2015) 0.81
Multiple courses of immunotherapy with different immune cell types for patients with hepatocellular carcinoma after microwave ablation. Exp Ther Med (2015) 0.80
Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells. World J Gastroenterol (2011) 0.80
Current status of multimodal & combination therapy for hepatocellular carcinoma. Indian J Med Res (2012) 0.78
Engineering α-fetoprotein-based gene vaccines to prevent and treat hepatocellular carcinoma: review and future prospects. Immunotherapy (2014) 0.78
Cytotoxicity of cytokine-induced killer cells targeted by a bispecific antibody to gastric cancer cells. Oncol Lett (2013) 0.77
Potentiality of immunotherapy against hepatocellular carcinoma. World J Gastroenterol (2015) 0.77
Harms and benefits of adoptive immunotherapy for postoperative hepatocellular carcinoma: an updated review. Oncotarget (2017) 0.77
Adjuvant Cytokine-Induced Killer Cell Therapy Improves Disease-Free and Overall Survival in Solitary and Nonmicrovascular Invasive Hepatocellular Carcinoma After Curative Resection. Medicine (Baltimore) (2016) 0.77
PD-L1 expression as a predictive biomarker for cytokine-induced killer cell immunotherapy in patients with hepatocellular carcinoma. Oncoimmunology (2016) 0.76
Immunobiology of hepatocarcinogenesis: Ways to go or almost there? World J Gastrointest Pathophysiol (2016) 0.76
Efficacy of RetroNectin-activated cytokine-induced killer cell therapy in the treatment of advanced hepatocelluar carcinoma. Oncol Lett (2016) 0.75
Timely meta-analysis on the efficacy of adoptive immunotherapy for hepatocellular carcinoma patients after curative therapy. PLoS One (2017) 0.75
Immune-Mediated Therapies for Liver Cancer. Genes (Basel) (2017) 0.75
Cytokine-induced killer cell therapy for the treatment of primary hepatocellular carcinoma subsequent to liver transplantation: A case report. Oncol Lett (2016) 0.75
Increased survival time of a patient with metastatic malignant melanoma following immunotherapy: A case report and literature review. Oncol Lett (2015) 0.75
Dual Functional Capability of Dendritic Cells - Cytokine-Induced Killer Cells in Improving Side Effects of Colorectal Cancer Therapy. Front Pharmacol (2017) 0.75
Efficacy of cytokine-induced killer cell infusion as an adjuvant immunotherapy for hepatocellular carcinoma: a systematic review and meta-analysis. Drug Des Devel Ther (2017) 0.75
Chemotherapy with or without autologous cytokine-induced killer cell transfusion as the first-line treatment for stage IV gastrointestinal cancer: a phase II clinical trial. J Cancer Res Clin Oncol (2016) 0.75
Clinical effects of autologous cytokine-induced killer cell-based immunotherapy in the treatment of endometrial cancer: a case report and literature review. Onco Targets Ther (2017) 0.75
A different representation of natural T cells and natural killer cells between tumor-infiltrating and periphery lymphocytes in human hepatocellular carcinoma. Oncol Lett (2017) 0.75
Structure-based prediction of protein-protein interactions on a genome-wide scale. Nature (2012) 3.37
Identification of a domain within peroxisome proliferator-activated receptor gamma regulating expression of a group of genes containing fibroblast growth factor 21 that are selectively repressed by SIRT1 in adipocytes. Mol Cell Biol (2007) 2.12
C/EBPalpha and the corepressors CtBP1 and CtBP2 regulate repression of select visceral white adipose genes during induction of the brown phenotype in white adipocytes by peroxisome proliferator-activated receptor gamma agonists. Mol Cell Biol (2009) 1.98
SirT1 regulates adipose tissue inflammation. Diabetes (2011) 1.39
Inhibition of Notch uncouples Akt activation from hepatic lipid accumulation by decreasing mTorc1 stability. Nat Med (2013) 1.23
Dissociation of the glucose and lipid regulatory functions of FoxO1 by targeted knockin of acetylation-defective alleles in mice. Cell Metab (2011) 1.18
Adrenal ganglioneuromas: a 10-year experience in a Chinese population. Surgery (2010) 1.14
Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol (2011) 1.14
Diagnostic performance of CareStart™ malaria HRP2/pLDH (Pf/pan) combo test versus standard microscopy on falciparum and vivax malaria between China-Myanmar endemic borders. Malar J (2013) 1.06
Alterations in the cortical thickness and the amplitude of low-frequency fluctuation in patients with post-traumatic stress disorder. Brain Res (2012) 1.04
The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). BMC Med Genet (2013) 1.03
SIRT1 controls lipolysis in adipocytes via FOXO1-mediated expression of ATGL. J Lipid Res (2011) 1.03
Inactivation of arf-bp1 induces p53 activation and diabetic phenotypes in mice. J Biol Chem (2011) 1.00
A quantitative anatomic study of plate-screw fixation of the acetabular anterior column through an anterior approach. Arch Orthop Trauma Surg (2010) 0.99
Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer. How do they measure up? Magn Reson Imaging (2010) 0.98
Foxo1 links hyperglycemia to LDL oxidation and endothelial nitric oxide synthase dysfunction in vascular endothelial cells. Diabetes (2009) 0.98
Clinical significance of lymph node metastasis in patients undergoing partial hepatectomy for hepatocellular carcinoma. World J Surg (2010) 0.98
Imaging findings of follicular dendritic cell sarcoma: report of four cases. Korean J Radiol (2011) 0.96
Levels of circulating Th17 cells and regulatory T cells in ankylosing spondylitis patients with an inadequate response to anti-TNF-α therapy. J Clin Immunol (2012) 0.92
Compact optical temporal differentiator based on silicon microring resonator. Opt Express (2008) 0.92
Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain. Bioorg Med Chem Lett (2009) 0.91
Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays. Cancer Cell Int (2012) 0.90
A comparison of melancholic and nonmelancholic recurrent major depression in Han Chinese women. Depress Anxiety (2011) 0.90
Swyer-James syndrome with peculiar course and ipsilateral pulmonary vein defect. Intern Med (2011) 0.88
Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis. Pathology (2007) 0.88
Nodular glomerular lesion: a later stage of diabetic nephropathy? Diabetes Res Clin Pract (2007) 0.87
MMP28 (epilysin) as a novel promoter of invasion and metastasis in gastric cancer. BMC Cancer (2011) 0.87
Microendoscopic discectomy, a less traumatic procedure for lumbar disk herniation. Chin J Traumatol (2007) 0.86
Roles for peroxisome proliferator-activated receptor γ (PPARγ) and PPARγ coactivators 1α and 1β in regulating response of white and brown adipocytes to hypoxia. J Biol Chem (2012) 0.86
Promoter of TFPI-2 is hypermethylated in Chinese pediatric acute myeloid leukemia. J Pediatr Hematol Oncol (2012) 0.82
RNAi silencing of c-Myc inhibits cell migration, invasion, and proliferation in HepG2 human hepatocellular carcinoma cell line: c-Myc silencing in hepatocellular carcinoma cell. Cancer Cell Int (2013) 0.82
A-ring modifications on the triazafluorenone core structure and their mGluR1 antagonist properties. Bioorg Med Chem Lett (2010) 0.81
Effects of manganese deficiency on serum hormones and biochemical markers of bone metabolism in chicks. J Bone Miner Metab (2013) 0.81
Design and synthesis of tricyclic sulfones as gamma-secretase inhibitors with greatly reduced Notch toxicity. Bioorg Med Chem Lett (2010) 0.80
Associations between RAS Gene polymorphisms, environmental factors and hypertension in Mongolian people. Eur J Epidemiol (2006) 0.80
Application of botulinum toxin type A in myocutaneous flap expansion. Plast Reconstr Surg (2009) 0.79
Inhibition of the ecto-beta subunit of F1F0-ATPase inhibits proliferation and induces apoptosis in acute myeloid leukemia cell lines. J Exp Clin Cancer Res (2012) 0.79
A new rhodamine-based colorimetric cyanide chemosensor: convenient detecting procedure and high sensitivity and selectivity. ACS Appl Mater Interfaces (2009) 0.79
Investigation of end-digit preference in blood pressure records of hospitalized chinese patients and analysis of risk factors. Postgrad Med (2012) 0.77
Analysis of molecular pathological factors of unfavorable prognosis for young cervical cancer patients. Onkologie (2007) 0.77
Synthesis and SAR development of novel mGluR1 antagonists for the treatment of chronic pain. Bioorg Med Chem Lett (2012) 0.76
Oxidative stress status in umbilical cord blood from neonates born to mothers with atopic asthma. J Matern Fetal Neonatal Med (2013) 0.76
Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine. Vaccine (2008) 0.76
Prognosis in patients with small hepatocellular carcinoma: a meta-analysis. Hepatogastroenterology (2011) 0.75
Fluorescent carbon dots for biolmaging and biosensing applications. J Biomed Nanotechnol (2014) 0.75
Absence of the adenosine A(2A) receptor attenuates hypertrophic scarring in mice. J Burn Care Res (2013) 0.75
Novel aminobenzimidazoles as selective MCH-R1 antagonists for the treatment of metabolic diseases. Bioorg Med Chem Lett (2006) 0.75
Preparation of electrophoretic nanoparticles for electronic paper. J Nanosci Nanotechnol (2014) 0.75
A-ring modification of SCH 900229 and related chromene sulfone γ-secretase inhibitors. Bioorg Med Chem Lett (2012) 0.75
[Repair of lower extremity soft tissue defect with free musculo-cutaneous flaps bridging with healthy contralateral posterior tibial vessel]. Zhonghua Zheng Xing Wai Ke Za Zhi (2015) 0.75
Tricyclic sulfones as orally active gamma-secretase inhibitors: synthesis and structure-activity relationship studies. Bioorg Med Chem Lett (2010) 0.75
Modified Great Toe Wraparound Flap with Preservation of Plantar Triangular Flap for Reconstruction of Degloving Injuries of the Thumb and Fingers: Long-Term Follow-Up. Plast Reconstr Surg (2016) 0.75
Release within scar using the needle-scalpel for treatment of scar contracture of the neck. Plast Reconstr Surg (2010) 0.75
An overview on the pharmacokinetics of quantum dots. Curr Drug Metab (2013) 0.75
Luminescence properties of cubic HfO2-Sc2O3:Eu3+ nano-powders. J Nanosci Nanotechnol (2011) 0.75
Effect of ultrasound stimulation on metabolic modulation of pyruvic acid. Colloids Surf B Biointerfaces (2004) 0.75
Superparamagnetic Chitosan Nanoparticles for a Vancomycin Delivery System: Optimized Fabrication and Characterization. J Biomed Nanotechnol (2019) 0.75
Carbonic anhydrase: a key regulatory and detoxifying enzyme for Karst plants. Planta (2013) 0.75
[Transformation and expression of specific insecticide gene Bt cry3A in resident endogenetic bacteria isolated from Apriona germari (Hope) larvae intestines]. Wei Sheng Wu Xue Bao (2008) 0.75
[Research progress of the role of oxidative stress in the pathogenesis of COPD]. Zhonghua Jie He He Hu Xi Za Zhi (2015) 0.75
Synthesis and structure-activity relationships of piperidine-based melanin-concentrating hormone receptor 1 antagonists. Bioorg Med Chem Lett (2006) 0.75
Thumb fingertip reconstruction with palmar V-Y flaps combined with bone and nail bed grafts following amputation. Arch Orthop Trauma Surg (2015) 0.75
[Application of V-Y advanced flap pedicled with posterior perforator from medial malleolus for small skin defect at achilles tendon region]. Zhonghua Zheng Xing Wai Ke Za Zhi (2014) 0.75
[Effectiveness of improved interosseous dorsal artery reversed island flap for dorsal skin and soft tissue defect of hand]. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi (2014) 0.75
Luminescent electrophoretic particles via miniemulsion polymerization for night-vision electrophoretic displays. ACS Appl Mater Interfaces (2013) 0.75
[The establishment of craniopharyngioma cell line]. Sichuan Da Xue Xue Bao Yi Xue Ban (2011) 0.75
Linear and non-linear features of surface EMG during fatigue and recovery period. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Correlation between cerebral infarction and ALOX5AP gene expression. Cell Biochem Biophys (2013) 0.75
Synthesis of black magnetic electrophoretic particles for magnetic-electric dual-driven electronic paper. ACS Appl Mater Interfaces (2013) 0.75
Comparison of lumbar muscle sEMG between health and LBP patients during dynamic back extensions. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
[Recombinant adenovirus Ad-APN-EGFP constructing and promoting osteogenesis around implants]. Hua Xi Kou Qiang Yi Xue Za Zhi (2014) 0.75
[Postlaminectomy vertebral lamina reconstruction and pedicle screw reduction and fixation for lumbar spondylolisthesis]. Zhongguo Gu Shang (2012) 0.75
[Bacteriology study of hypospadias]. Zhonghua Zheng Xing Wai Ke Za Zhi (2005) 0.75